Drug based approaches for targeting tumor vasculature: Development of combretastatin A4 phosphate

被引：7
|
作者：
Chaplin, DJ [1 ]
机构：
[1] Oxigene Inc, Head R&D, Watertown, MA 02472 USA
来源：
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷
关键词：
D O I：
10.1159/000073279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics, excretion, and distribution of combretastatin A4 phosphate in rats
    Xu, Xiao-Ping
    Wu, Xiao-Dong
    Liang, Gui-Lun
    Huang, Wen-Sheng
    Wang, Li
    Jing, Hai-Ying
    Zhong, Shi-Long
    PHARMAZIE, 2012, 67 (06): : 529 - 533
  • [22] Combretastatin A4 phosphate: background and current clinical status
    Young, SL
    Chaplin, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) : 1171 - 1182
  • [23] Combretastatin A4 phosphate: a novel vascular disrupting agent
    Nagaiah, Govardhanan
    Remick, Scot C.
    FUTURE ONCOLOGY, 2010, 6 (08) : 1219 - 1228
  • [24] Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate
    Kirwan, IG
    Loadman, PM
    Swaine, DJ
    Anthoney, DA
    Pettit, GR
    Lippert, JW
    Shnyder, SD
    Cooper, PA
    Bibby, MC
    CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1446 - 1453
  • [25] A novel rodent in vivo tumor blood flow model:: selective effects of combretastatin A4 and A-318315 on tumor vasculature.
    Dierks, KA
    Segreti, JA
    Polakowski, JS
    Rosenberg, SH
    Sham, HL
    Cox, BF
    Reinhart, GA
    FASEB JOURNAL, 2002, 16 (04): : A87 - A87
  • [26] Combretastatin A4 disodium phosphate-induced myocardial injury
    Tochinai, Ryota
    Nagata, Yuriko
    Ando, Minoru
    Hata, Chie
    Suzuki, Tomo
    Asakawa, Naoyuki
    Yoshizawa, Kazuhiko
    Uchida, Kazumi
    Kado, Shoichi
    Kobayashi, Toshihide
    Kaneko, Kimiyuki
    Kuwahara, Masayoshi
    JOURNAL OF TOXICOLOGIC PATHOLOGY, 2016, 29 (03) : 163 - 171
  • [27] Antineoplastic effects of Endostar combined with combretastatin A4 phosphate in vitro
    Fu, Xianhua
    Duan, Yin
    Shen, Hongdan
    Zou, Yong
    Pan, Chi
    Lu, Demin
    Huang, Jianjin
    Li, Jun
    Zhang, Suzhan
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 578 - 586
  • [28] Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia
    Eikesdal, HP
    Bjerkvig, R
    Raleigh, JA
    Mella, O
    Dahl, O
    RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) : 313 - 320
  • [29] Stimulation of Eryptosis by Combretastatin A4 Phosphate Disodium (CA4P)
    Signoretto, Elena
    Bissinger, Rosi
    Castagna, Michela
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (03) : 969 - 981
  • [30] Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo
    Galbraith, SM
    Chaplin, DJ
    Lee, F
    Stratford, MRL
    Locke, RJ
    Vojnovic, B
    Tozer, GM
    ANTICANCER RESEARCH, 2001, 21 (1A) : 93 - 102
12345